Cookies on Pinsent Masons website

This website uses cookies to allow us to see how the site is used. The cookies cannot identify you. If you continue to use this site we will assume that you are happy with this

If you want to use the sites without cookies or would like to know more, you can do that here.

Keeping Pharma’s House in Order

Bribery and corruption are two major problems in any industry, and Big Pharma
is not exempt. As regulators look to tackle this problem, coming down hard
on perpetuators, pharma companies need to ensure that their compliance
programmes are in place and updated to reflect new developments in the law.

Originally published in the December 2012 issue of Innovations in Pharmaceutical Technology (IPT).

Read the article here

Key Contacts